BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed BAX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:20e9f9333b5fad2f7f2e@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260814
DTEND;VALUE=DATE:20260815
SUMMARY:BAX APPROVAL: SODIUM BICARBONATE
DESCRIPTION:Approved 2026-08-14: SODIUM BICARBONATE (NDA218524 ORIG1)\nConf
 idence: confirmed\nTicker BAX (confidence 0.6)\nSource: https://www.access
 data.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2185
 24\nScheduling/reference data from public records\; dates can move. Not in
 vestment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=218524
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:47204dd6da4fb208d154@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260330
DTEND;VALUE=DATE:20260331
SUMMARY:BAX APPROVAL: EPINEPHRINE
DESCRIPTION:Approved 2026-03-30: EPINEPHRINE (NDA220626 ORIG1)\nConfidence:
  confirmed\nTicker BAX (confidence 0.6)\nSource: https://www.accessdata.fd
 a.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220626\nSch
 eduling/reference data from public records\; dates can move. Not investmen
 t\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=220626
CATEGORIES:approval,confirmed
END:VEVENT
END:VCALENDAR
